QUILT-3.011

brachyury-targeted yeast vaccine · NantCell, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for QUILT-3.011, covering 2024-05-20 to 2024-05-20. Get the full timeline:

Most recent: Clinical Trial Update: QUILT-3.011 Phase 2 Yeast-Brachyury Vaccine Chordoma [Phase 2]